Literature DB >> 2112296

Small bowel permeability to 51Cr-EDTA in children with recurrent abdominal pain.

S B van der Meer1, P P Forget, G A Heidendal.   

Abstract

Small bowel permeability was investigated in 87 children with recurrent abdominal pain by measuring the 24-h urinary excretion of orally administered 51Cr-EDTA. The mean excretion was 3.64% +/- 1.49% per 24 h. The difference between the mean urinary excretion in children with recurrent abdominal pain and control children (2.51% +/- 0.70%), was significant (p less than 0.01, two sample t-test). The increased small bowel permeability in children with recurrent abdominal pain might indicate an intestinal etiology for the patients' complaints.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112296     DOI: 10.1111/j.1651-2227.1990.tb11487.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  5 in total

1.  Management of recurrent abdominal pain.

Authors:  M S Murphy
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

2.  Diagnostic value of ultrasound in children with recurrent abdominal pain.

Authors:  S B van der Meer; P P Forget; J W Arends; R H Kuijten; J M van Engelshoven
Journal:  Pediatr Radiol       Date:  1990

3.  Abnormal small bowel permeability and duodenitis in recurrent abdominal pain.

Authors:  S B van der Meer; P P Forget; J W Arends
Journal:  Arch Dis Child       Date:  1990-12       Impact factor: 3.791

4.  Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome.

Authors:  Robert J Shulman; Michelle N Eakin; Danita I Czyzewski; Monica Jarrett; Ching-Nan Ou
Journal:  J Pediatr       Date:  2008-06-09       Impact factor: 4.406

5.  The prevalence of Helicobacter pylori serum antibodies in children with recurrent abdominal pain.

Authors:  S B van der Meer; P P Forget; R J Loffeld; E Stobberingh; R H Kuijten; J W Arends
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.